Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | PD184352 | 0.1 | uM | 1 | IL-13 | 40.5 | 78 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 1 | IL-13 | 41.5 | 70 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 1 | IL-13 | 31.0 | 69 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | IL-13 | 47.0 | 49 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | IL-13 | 38.5 | 92 | ||||
| N2586 | 1 | IL-13 | 42.0 | 56 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 1 | IL-13 | 31.5 | 64 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 41.5 | 70 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 38.0 | 65 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 34.5 | 78 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 34.0 | 47 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 30.0 | 57 | |
| N2586 | Visfatin | 1 | ng/mL | 1 | IL-13 | 36.0 | 52 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 27.5 | 56 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 30.0 | 53 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 27.0 | 63 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 30.0 | 64 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-13 | 30.0 | 25 | |
| 0 | IL-13 | 14.0 | 65 | ||||||||
| RA2159 | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 35.5 | 50 | ||||
| RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 47.0 | 51 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 77.5 | 66 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 35.5 | 48 | |
| RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 37.0 | 66 | |
| RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-13 | 26.5 | 50 |